Traphaco continues to succeed with high-quality Eastern medicine and high-quality Western medicine

Eastern medicine always leads in revenue with new attraction from high-end product lines; Western medicine grows every year, which is proof of the durability of the strategy chosen by Traphaco.

Unlimited green medicinal areas To ensure the highest standards of quality of Oriental medicine products, Traphaco CNC - a member of the Traphaco family has pioneered the journey to expand green medicinal areas. All processes from soil quality testing, irrigation water sources to the growing environment strictly follow GACP-WHO standards to ensure optimal quality of medicinal herbs. The planting, care, harvesting and processing processes are developed by Traphaco CNC in cooperation with research centers and agricultural experts, ensuring efficiency, productivity, quality and environmental friendliness.

Traphaco expands medicinal herb area meeting GACP-WHO standards. PHOTO: NG.HUY

Pharmacist Nguyen Ngoc Thanh (Traphaco CNC Business Development Department) shared passionately:   The growing areas are closely monitored from seed selection to harvest. The preliminary processing and processing stages are all carried out at the company's GMP-certified factory, and medicinal samples are thoroughly tested to ensure quality in accordance with pharmacopoeia standards. Mr. Thanh said that the yellow chrysanthemum, a flower with bright sunshine and strong vitality, when growing medicinal herbs requires very strict requirements on soil quality and harvesting time. Or with wild plants such as stevia and mugwort, we also have to survey and evaluate the growth and active ingredient content at different times of the year to have a harvesting and processing schedule with the highest active ingredient content.

"Each small pill that reaches the user carries the efforts, dedication, and passion of the Traphaco CNC team and its partners," said Dr. Thanh. By October 2024, Traphaco CNC had built and achieved GACP-WHO certification for 5 medicinal herbs: Golden Chrysanthemum, Alisma, Periwinkle, Sweet Grass, and Mugwort. The company also developed other medicinal herbs according to GACP-WHO standards such as: Dioscorea, Cassia seed, Rehmannia glutinosa, and Motherwort. Reaching the strategic level of high-quality Oriental medicine and high-quality Western medicine After 30 years of working with Traphaco, MSc. Dao Thuy Ha, Deputy General Director of Traphaco Joint Stock Company, acknowledged that after more than half a century of development, Traphaco has affirmed its pioneering position in the Vietnamese pharmaceutical industry through the combination of tradition and modernity. Traphaco's strategy of "High-quality Oriental Medicine - High-quality Modern Medicine" is not only a breakthrough in business but also a testament to its commitment to bringing sustainable values ​​to the community and society. With its strength in Oriental Medicine, Traphaco has built a foundation from products that have been trusted by consumers for many generations such as Boganic and Hoat Huyet Duong Nao. To bring Oriental Medicine to a new level, Traphaco has developed medicinal herb areas that meet GACP-WHO standards across the country, from artichoke in Sa Pa to bitter ground vegetables in Phu Yen. These growing areas not only provide high-quality raw materials but also bring stable income to local people, contributing to building a sustainable economy .

Not stopping there, Traphaco has developed a line of high-end oriental medicine products with clear criteria: combining the quintessence of traditional medicine with modern technology and aiming for environmental and social sustainability. Sales of nearly 70 billion VND in the first 10 months of 2024 are strong proof of the potential and attractiveness of this high-end product line. Strong investment in modern medicine Along with oriental medicine, with a long-term vision to meet the increasing demand for products that meet international quality standards, Traphaco has invested heavily in modern medicine. Currently, Traphaco's modern medicine factory has met GMP-WHO standards, with a production capacity of 500 million product units per year. One of the important steps forward of this modern medicine factory is the project to deploy a GMP-EU factory, the highest standard in the field of pharmaceutical production.

Traphaco is developing a pharmaceutical factory that meets GMP - EU standards, the highest standard for pharmaceutical quality. PHOTO: NG.HUY

Impressive figures affirm the potential of Traphaco's Western medicine products with a growth rate of 13% compared to 2023, showing the steady and sustainable progress of these products. Strategic cooperation with Daewoong Korea, from technology transfer to reducing production costs and improving quality, has given Traphaco competitive advantages in Western medicine products. Traphaco's strategy of "High-class Oriental Medicine - High-quality Western Medicine" is not only reflected in sales but also in positive impacts on society and the community, of which the company's GreenPlan Project is a typical example. GreenPlan conserves natural resources, improving the lives of thousands of families in medicinal herb growing areas. GreenPlan enhances brand value while building a sustainable development model, bringing long-term benefits to businesses and the community.

The combination of high-quality oriental medicine and high-quality modern medicine has created a solid foundation, helping Traphaco not only maintain its leading position in the domestic market but also be ready to conquer demanding international markets. This strategy will continue to be the guiding principle for Traphaco to maintain sustainable development and pioneer in the pharmaceutical industry.

Source: https://thanhnien.vn/traphaco-tiep-tuc-thanh-cong-voi-dong-duoc-cao-cap-va-tan-duoc-chat-luong-cao-185241121191422561.htm